Baha Sibai
Maternal & Fetal Medicine · Houston, TXNPI 1942381926
Payments from drug & device makers
What this record shows
This record is dominated by consulting fees: $125,750 of the $131,735 with a category attached, or 95.5%. AMAG Pharmaceuticals, Inc. accounts for 83.3% of it on its own, with 13 other manufacturers making up the rest. Reporting peaked in 2019 at $50,675 and has fallen 86.4% since, to $6,907 in 2025. Among maternal & fetal medicine clinicians in TX with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 85 payments — averaging $1549.83 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AMAG Pharmaceuticals, Inc.$110K
- Grifols Shared Services North America, Inc.$7K
- Sage Therapeutics, LLC$4K
- Quidel Corporation$3K
- Kyowa Kirin, Inc.$2K
- Roche Diagnostics Corporation$2K
- plus $4K from 8 others
Across 52 payments — averaging $13,568 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Kyowa Kirin Co., Ltd$414K
- AMAG Pharmaceuticals, Inc.$217K
- Siemens Medical Solutions USA, Inc.$75K
What the payments were for
- Consulting fees$125,75095%
- Travel & lodging$3,0932%
- Food & beverage$2,5762%
- Education$3160%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AMAG Pharmaceuticals, Inc. | 62 | $109,734 |
| Grifols Shared Services North America, Inc. | 8 | $6,907 |
| Sage Therapeutics, LLC | 3 | $4,005 |
| Quidel Corporation | 2 | $3,000 |
| Kyowa Kirin, Inc. | 1 | $2,400 |
| Roche Diagnostics Corporation | 1 | $2,000 |
| Janssen Global Services, LLC | 1 | $1,740 |
| Kyowa Kirin Co., Ltd | 1 | $800 |
| Vertex | 1 | $525 |
| Xellia Pharmaceuticals | 1 | $500 |
| Tandem Diabetes Care, Inc. | 1 | $61 |
| Dexcom, Inc. | 1 | $26 |
| Bayer | 1 | $20 |
| Daiichi Sankyo Inc. | 1 | $19 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- MAKENA$105,867
- FERAHEME$11,198
- INTRAROSA$9,688
- ZULRESSO$2,225
- CD cobas Reagents$2,000
How this compares
$131,735 in reported general payments places this provider in the 95th percentile of 228 maternal & fetal medicine providers in Texas.
Other maternal & fetal medicine in Houston
- Jimmy EspinozaHouston$79K
- Sean BlackwellHouston$16K
- Saul SnowiseHouston$15K
- Anushka ChelliahHouston$8K
- Lara FrielHouston$5K
- Brian KirshonHouston$5K
- Karin FoxHouston$4K
- Irene StaffordHouston$4K
- Ignatia van Den VeyverHouston$4K
- Hailey HallHouston$3K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.